Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Eurobio Scientific (ALERS) EUR0.32

Sell:€3.80 Buy:€3.88 Change: €0.01 (0.26%)
Market closed |  Prices as at close on 17 October 2019 | Switch to live prices |
Sell:€3.80
Buy:€3.88
Change: €0.01 (0.26%)
Market closed |  Prices as at close on 17 October 2019 | Switch to live prices |
Sell:€3.80
Buy:€3.88
Change: €0.01 (0.26%)
Market closed |  Prices as at close on 17 October 2019 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Eurobio Scientific SA, formerly Diaxonhit, is a France-based biotechnology company engaged in the field of in-vitro diagnostic. It is engaged in activities ranging from discovery to the commercialization of specialty diagnostic products. The Company owns a portfolio of diagnostic products in three specialty areas: infectious diseases; Alzheimer's disease, and cancer. It consists of Tetanos Quick Stick (TQS), which is an unitary test enabling to determine the tetanus vaccination status. It has a portfolio of in-house and co-developed products, including AclarusDx (a blood-based test for the detection of biomarkers specific for Alzheimer's disease). The portfolio includes BJI Inoplex for prosthetic infections and EHT Dx14 for breast cancer (both in validation phase). The co-developed products include research programs for the identification of predictive biomarkers of response for anti-HER2 and anti-angiogenic therapies, among others. It operates through Genbio and Eurobio Capforce Plus.

Contact details

Address:
Les Ulis Cedex
LES ULIS
91953
France
Telephone:
+33 (1) 53947700
Website:
www.diaxonhit.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ALERS
ISIN:
FR0013240934
Market cap:
€43.74 million
Shares in issue:
9.87 million
Sector:
Biotechnology
Exchange:
Euronext Paris
Country:
Unclassified
Currency:
Euro
Indices:
n/a

Key personnel

  • Laurent Condomine
    Chairman of the Supervisory Board
  • Loic Maurel
    Chairman of the Management Board, Director of Operations and Member of the Executive Committee
  • Jean-Pierre Hermet
    Vice Chairman of the Supervisory Board
  • Herve Duchesne de Lamotte
    Chief Financial and Administrative Officer, Member of the Management Board and Member of the Executive Committee
  • Jacques Martin
    Member of the Executive Committee and Vice President Marketing
  • Thomas Iff
    Chief Business Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.